| Date Filed | Type | Description |
| 08/16/2011 |
BW
| POZEN Welcomes Clint Burrus as Vice President, Customer Development |
| 07/14/2011 |
BW
| POZEN Announces July 28, 2011 Webcast of Second Quarter 2011 Results |
| 07/12/2011 |
BW
| POZEN Announces Tomas S. Bocanegra, M.D. as Head of Development |
| 06/09/2011 |
BW
| POZEN to Present at the 2011 Wells Fargo Securities Healthcare Conference |
| 05/25/2011 |
BW
| POZEN Ranked as Second Most Efficient Pharma Company by SmarTrend |
| 05/24/2011 |
BW
| POZEN to Present at the Jefferies 2011 Global Life Sciences Conference |
| 05/05/2011 |
BW
| POZEN Reports First Quarter 2011 Results |
| 04/15/2011 |
BW
| Preliminary Injunction Ordered in POZEN Treximet Patent Litigation |
| 03/24/2011 |
BW
| POZEN Reports Superior Platelet Inhibition of PA32540 Regimen Over a Standard of Care Regimen in a Phase 1 Study (“Co-Rx”) |
| 03/24/2011 |
BW
| POZEN To Present at the 10th Annual Needham Healthcare Conference |
| 03/23/2011 |
BW
| POZEN Announces Licensing Deal with Cilag GmbH, A Division of Johnson & Johnson, for MT 400, Migraine Treatment |
| 03/22/2011 |
BW
| POZEN Files Motion for Preliminary Injunction in Treximet Patent Litigation |
| 02/24/2011 |
BW
| POZEN Announces March 9, 2011 Webcast of Fourth Quarter & Year End 2010 Results |
| 02/22/2011 |
BW
| POZEN Announces Addition to Commercial Team |
| 11/19/2010 |
BW
| POZEN to Present at the 22nd Annual Piper Jaffray Healthcare Conference |
| 11/14/2010 |
BW
| POZEN PA32540 Phase 1 Data Presented at The American Heart Association Scientific Sessions |
| 11/05/2010 |
BW
| POZEN Statement on FDA Gastrointestinal Drugs Advisory Committee Meeting |
| 11/02/2010 |
BW
| Three POZEN Projects Selected for Therapeutic Discovery Grants |
| 10/28/2010 |
BW
| POZEN Reports Third Quarter 2010 Results |
| 10/14/2010 |
BW
| POZEN Announces October 28, 2010 Webcast of Third Quarter 2010 Results |
| 09/08/2010 |
BW
| POZEN To Present at the UBS 2010 Global Life Sciences Conference |
| 08/03/2010 |
BW
| POZEN Reports Second Quarter Profit; Results Reflect $20 Million Milestone Payment For VIMOVO™ |
| 07/22/2010 |
BW
| POZEN To Present at The BMO Capital Markets Focus on Healthcare Conference |
| 07/21/2010 |
BW
| POZEN Announces August 3, 2010 Webcast of Second Quarter 2010 Results |
| 06/16/2010 |
BW
| POZEN to Present at the Wells Fargo Securities 3rd Annual Healthcare Conference |
| 06/15/2010 |
BW
| POZEN Announces Election of Neal F. Fowler to the Board of Directors |
| 05/06/2010 |
BW
| POZEN Reports PA65020 Significantly Reduces the Incidence of Upper GI Damage in Healthy Adults |
| 05/03/2010 |
BW
| REPEAT/POZEN Announces May 3, 2010 Webcast |
| 04/30/2010 |
BW
| POZEN Announces May 3, 2010 Webcast |
| 04/29/2010 |
BW
| POZEN Reports First Quarter 2010 Results |
| 04/21/2010 |
BW
| POZEN Announces April 29, 2010 Webcast of First Quarter 2010 Results |
| 03/03/2010 |
BW
| POZEN Reports Fourth Quarter/Year End 2009 Results |
| 02/24/2010 |
BW
| POZEN Announces March 3, 2010 Webcast of Fourth Quarter and Year End 2009 Results |
| 02/22/2010 |
BW
| POZEN to Present at the Cowen & Company 30th Annual Healthcare Conference |